CUI1 stringlengths 8 8 | RELA stringlengths 3 54 | CUI2 stringlengths 8 8 | Name1 stringlengths 1 2.86k ⌀ | Name2 stringlengths 1 2.86k ⌀ | Def1 stringlengths 1 8.95k ⌀ | Def2 stringlengths 1 8.95k ⌀ |
|---|---|---|---|---|---|---|
C0000618 | mapped_to | C1174520 | mercaptopurine | ALL-85 protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C1455642 | mercaptopurine | azathiopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C1566498 | mercaptopurine | APO combination | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C1566600 | mercaptopurine | ALL-BFM-95 protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C1872713 | mercaptopurine | POG-8498 protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C1958733 | mercaptopurine | S6-methylthio-2-aminopurne | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C2355147 | mercaptopurine | 6-carboxymethylthiopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C3492571 | mercaptopurine | 2,8-dimercapto-6-hydroxypurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C3657821 | mercaptopurine | 6-((1-naphthylmethyl)sulfanyl)-9H-purine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | mapped_to | C4506873 | mercaptopurine | B-0N compound | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | inverse_isa | C0280038 | mercaptopurine | Purine antagonist | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | An antimetabolite that affects the metabolism and utilization of purines. |
C0000618 | inverse_isa | C1268902 | mercaptopurine | Purine analog | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | synthetic or natural chemical compounds which resemble naturally occurring purine in structure and/or function. |
C0000618 | has_causative_agent | C0274577 | mercaptopurine | Poisoning by mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0413640 | mercaptopurine | Mercaptopurine adverse reaction | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0568066 | mercaptopurine | Accidental mercaptopurine poisoning | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0568067 | mercaptopurine | Intentional mercaptopurine poisoning | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0568068 | mercaptopurine | poisoning by mercaptopurine, undetermined intent | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0570694 | mercaptopurine | Allergy to mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0572592 | mercaptopurine | Mercaptopurine overdose | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0572593 | mercaptopurine | Accidental mercaptopurine overdose | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0572594 | mercaptopurine | Intentional mercaptopurine overdose | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_causative_agent | C0572595 | mercaptopurine | Mercaptopurine overdose of undetermined intent | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_active_ingredient | C0689485 | mercaptopurine | mercaptopurine 50 MG Oral Tablet | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_basis_of_strength_substance | C0689485 | mercaptopurine | mercaptopurine 50 MG Oral Tablet | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_precise_active_ingredient | C0689485 | mercaptopurine | mercaptopurine 50 MG Oral Tablet | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1266589 | mercaptopurine | Mercaptopurine measurement | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C2711674 | mercaptopurine | Quantitative measurement of mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_active_ingredient | C3219954 | mercaptopurine | mercaptopurine Oral Product | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_basis_of_strength_substance | C3817479 | mercaptopurine | mercaptopurine 20 MG/ML Oral Suspension | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_precise_active_ingredient | C3817479 | mercaptopurine | mercaptopurine 20 MG/ML Oral Suspension | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_direct_substance | C4510391 | mercaptopurine | Mercaptopurine therapy | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | disposition_of | C4542542 | mercaptopurine | Antimetabolite (disposition) | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning. |
C0000618 | has_active_ingredient | C4753951 | mercaptopurine | Mercaptopurine only product | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_active_ingredient | C4756942 | mercaptopurine | Mercaptopurine only product in oral dose form | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | associated_with | C5683933 | mercaptopurine | long-term use of 6-mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C5876621 | mercaptopurine | mercaptopurine in serum or plasma | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | isa | C0689485 | mercaptopurine | mercaptopurine 50 MG Oral Tablet | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | isa | C3219954 | mercaptopurine | mercaptopurine Oral Product | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | isa | C4753951 | mercaptopurine | Mercaptopurine only product | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | inverse_isa | C0003376 | mercaptopurine | Antimetabolites | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) |
C0000618 | inverse_isa | C0003392 | mercaptopurine | Antineoplastic Agents | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | Substances that inhibit or prevent the proliferation of NEOPLASMS. |
C0000618 | inverse_isa | C5545756 | mercaptopurine | Purine and/or purine derivative-containing product | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_measured_component | C1266589 | mercaptopurine | Mercaptopurine measurement | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | active_ingredient_of | C1268902 | mercaptopurine | Purine analog | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | synthetic or natural chemical compounds which resemble naturally occurring purine in structure and/or function. |
C0000618 | role_played_by | C4751301 | mercaptopurine | Antineoplastic therapeutic role | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0550716 | mercaptopurine | Mercaptopurine:MCnc:Pt:Ser/Plas:Qn | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0800376 | mercaptopurine | Mercaptopurine:PrThr:Pt:Ser/Plas:Ord | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C1715013 | mercaptopurine | Mercaptopurine:PrThr:Pt:Bld:Ord | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C0722911 | mercaptopurine | Purinethol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | lab_number_of | C0729098 | mercaptopurine | BW 57-323H | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C0729099 | mercaptopurine | Leukerin | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513134 | mercaptopurine | Alti-Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513135 | mercaptopurine | Flocofil | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513136 | mercaptopurine | Ismipur | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513137 | mercaptopurine | Mercaleukim | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513138 | mercaptopurine | Mercaptina | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C1513139 | mercaptopurine | Purinethiol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | lab_number_of | C1522533 | mercaptopurine | U-4748 | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | lab_number_of | C1522534 | mercaptopurine | WR-2785 | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C3819063 | mercaptopurine | Purixan | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | tradename_of | C3827179 | mercaptopurine | Xaluprine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0057181 | mercaptopurine | cytarabine/daunorubicin/mercaptopurine/prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of cytarabine, daunorubicin, mercaptopurine, and prednisolone that may be used in the treatment of acute myeloid leukemia (AML). |
C0000618 | has_component | C0278667 | mercaptopurine | Asparaginase/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278668 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278705 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278896 | mercaptopurine | Carmustine/Cyclophosphamide/Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278902 | mercaptopurine | Asparaginase/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278903 | mercaptopurine | Asparaginase/Doxorubicin/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278905 | mercaptopurine | Mercaptopurine/Methotrexate/Prednisone/Vindesine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278916 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate Combination | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278923 | mercaptopurine | Cyclophosphamide/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278924 | mercaptopurine | Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0278933 | mercaptopurine | Mercaptopurine/Methotrexate/Pentostatin | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279062 | mercaptopurine | Cyclophosphamide/Cytarabine/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279080 | mercaptopurine | Cytarabine/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279247 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279276 | mercaptopurine | doxorubicin/mercaptopurine/prednisone/vincristine protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279351 | mercaptopurine | Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279391 | mercaptopurine | mercaptopurine/methotrexate/vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279444 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Prednisone/Vincristine Regimen | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of vincristine, cyclophosphamide, mercaptopurine, and prednisone that may be used in the treatment of central nervous system (CNS) lymphoma. |
C0000618 | has_component | C0279463 | mercaptopurine | Cytarabine/Doxorubicin/Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279469 | mercaptopurine | Cytarabine/Doxorubicin/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279537 | mercaptopurine | Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0279859 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280024 | mercaptopurine | mercaptopurine/methotrexate/prednisolone/vincristine protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280064 | mercaptopurine | Carmustine/Mercaptopurine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280075 | mercaptopurine | mercaptopurine/methotrexate/methylprednisolone/vincristine protocol | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280525 | mercaptopurine | Mercaptopurine/Methotrexate Regimen | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | A regimen consisting of mercaptopurine and methotrexate that may be used in the treatment of acute lymphoblastic leukemia (ALL). |
C0000618 | has_component | C0280528 | mercaptopurine | Mercaptopurine/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280642 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280643 | mercaptopurine | Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisolone/Teniposide/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280649 | mercaptopurine | Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Teniposide | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280729 | mercaptopurine | Dactinomycin/Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280730 | mercaptopurine | Carmustine/Cyclophosphamide/Dactinomycin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280775 | mercaptopurine | Cyclophosphamide/Etoposide/Mercaptopurine/Methotrexate | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280777 | mercaptopurine | Cyclophosphamide/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0280821 | mercaptopurine | Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281012 | mercaptopurine | Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim/Mercaptopurine/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281018 | mercaptopurine | Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
C0000618 | has_component | C0281119 | mercaptopurine | Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Vincristine | An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.